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Accepted 23 June 2020Purpose: This study sought to determine the prevalence ofmenstrual migraine among female university students
at the Nursing Faculty of Ciudad Real and to determine possible risk factors.
Design and methods: A cross-sectional observational study was performed using a self-report questionnaire. Two
hundred and ninety-nine female university students participated in the study; all were enrolled in the 2017/2018
academic year at the Faculty of Nursing. Participants were over the age of 18 years and without any diagnosed
gynecological pathology. The main measurement tools were menstrual migraine between days −2 and +3 of
the menstrual cycle, over the previous six cycles.
Results: The prevalence of menstrual migraine was 45.15%, identifying the following possible risk factors: dys-
menorrhea (OR 9.19; 1.62–6.28% CI), use of hormonal contraceptivemethods (OR 2.60; 95% CI 1.30–5.20), men-
strual irritability (OR 2.34; 95% CI 1.25–4.40), menstrual dizziness (OR 2.05; 95% CI % 1.12–3.75) and daily
consumption of cola beverages (OR 1.85; 95% CI % 1.04–3.32).
Conclusions: The prevalence of this problem is high among our population and the approach is complex.
Practice implications: It is necessary to continue to research the pharmacologicalmeasures andmethods of phar-
macological pain relief as well as interventions directed at lifestyle modifications considering the potential risk
factors involved in menstrual migraine.




Migraine is one of themost common neurological disorders which is
more prevalent in women, compared to men, after puberty (Broner,
Bobker, & Klebanoff, 2017; Lay & Broner, 2008). Throughout this period,
the hypothalamus-hypophysis-gonadal axis is activated during the ini-
tial menstrual cycles. The hormonal deprivation which is triggered by
each menstruation, together with the decrease of estrogens and in-
crease of prostaglandins, are all factors considered to be responsible
for menstrual migraine (Silberstein & Patel, 2014).
Menstrual migraine can be categorized into migraines related with
menstruation and pure menstrual migraines. Pure menstrual migraines






L.(M.L.) Parra-Fernández).according to the 3rd Edition of the International Classification of Head-
ache Disorders published in 2018 by the International Headache Soci-
ety. Furthermore, these are more clearly identified when they occur
without aura between days−2 and+3 of themenstrual cycle, often ac-
companied by nausea and vomiting (“Headache Classification
Committee of the International Headache Society (IHS) The
International Classification of Headache Disorders, 3rd Edition”, 2018).
In addition, these migraines are characterized by triggering a greater
functional decline compared to non-menstrual migraines (MacGregor
et al., 2010). Menstrual migraine is considered to affect a large percent-
age of young women worldwide, however, few previous studies have
estimated these rates, and the reported rates are highly variable, rang-
ing from 1% to 28% (Bianchin et al., 2019; Maasumi, Tepper, &
Kriegler, 2017; Vetvik, MacGregor, Lundqvist, & Russell, 2014). More
concretely, in Spain, there is a lack of specific studies on this subject.
Headaches can affect quality of life, academic and work performance
and even limit activities of daily living; thus they have a significant so-
cial and economic impact (Lay & Broner, 2008; Mannix, 2008).
In relation to this problem, a specific and early approach is essential
to avoid chronification in adulthood, and headaches becoming a
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treatment, current approaches are mainly centered on triptans, anti-
inflammatories and hormonal treatments. Nonetheless, these treat-
ments are not without risks, therefore, research on risk factors and
non-pharmacological measures are increasingly in demand (Allais,
Chiarle, Sinigaglia, & Benedetto, 2018; Mannix, 2008). Pediatric nurses
should be updated on the prevalence of this problem in young people
and the possible associated risk factors as they can act as facilitators of
new health behaviours.
Themain aim of this studywas to determine the prevalence of men-
strual migraine (pure menstrual migraine) among female university
students and to identify possible risk factors.Methods
Design
This was a descriptive, quantitative observational study conducted
at the Nursing Faculty of Ciudad Real, belonging to the University of
Castilla-La-Mancha, between May and June of 2017.Participants and sample
The eligibility criteria for this study included students enrolled
in the Nursing Degree taught at the University of Castilla-La
Mancha (Ciudad Real Campus) and who were present in the class-
room when the researcher visited the university to invite them to
participate and collect data. The following inclusion criteria were
established: being a woman, over the age of 18 years, not diag-
nosed with a gynecological pathology (except for dysmenorrhea)
and of Spanish nationality. We excluded foreign university stu-
dents who suffered with others chronic pathologies, those who
were participated on a faculty exchange program, and women
who did not accept to voluntarily participate in the study or who
did not fully complete the study survey.
The sample size was not previously calculated, rather, the entire
study population were invited to participate (340 university students)
provided they fulfilled the previously described criteria. Of these, 299
students (87.94%) accepted to participate in this study and returned
the fully completed questionnaires. See study diagram (Fig. 1).Fig. 1. Study diagram.
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Study variables and data collection
The data were collected in the faculty classrooms via an ad-hoc self-
report questionnaire based on previous reports, which included
sociodemographic information, questions on menstruation, menstrual
migraine, menstrual symptoms and lifestyles (Ansong, Arhin, Cai, Xu,
& Wu, 2019; Fernández-Martínez, Onieva-Zafra, & Parra-Fernández,
2018; Vetvik et al., 2014). Themain study variable, menstrual migraine,
was defined as a headache occurring between days −2 and +3 of the
menstrual cycle for at least two out of every three cycles, according to
the criteria of the International Headache Society (IHS), and over the
last six months (“Headache Classification Committee of the
International Headache Society (IHS) The International Classification
of Headache Disorders, 3rd Edition”, 2018). Other menstrual symptoms
were considered if they were experienced in the six months prior to
responding to the questionnaire. To measure the intensity of pain, a
10 cm horizontal visual analog scale (VAS) was included (Collins,
Moore, & McQuay, 1997; Hawker, Mian, Kendzerska, & French, 2011).
The anthropometric measures, such as weight and height, were also
gathered via self-report and the BodyMass Index (BMI)was then calcu-
lated and categorized according to the indications by the World Health
Organization (WHO), thus, a BMI of less than 18.5 was classified as low
weight, 18.5 to 24.99was classified as normal weight, 25.0 to 29.99 was
classified as overweight (pre-obesity), and 30 or more was classified as
obesity (WHO, 2014). In addition, as in previous studies, the measure-
ment of the global health status on perceived quality of lifewas included
based on a visual analog scale (VAS) from 0 to 100, in which 0 indicated
the worse possible health state and 100 was the best health state
(Hernandez et al., 2018).
Ethics
Ethical approval for this study was granted by the Clinical Research
Ethics Committee of the General Hospital of Ciudad Real. The study pro-
cedures complied with the principles of the Helsinki Declaration.
Statistical analysis
The data were transcribed into a Microsoft Office Excel spreadsheet,
and subsequently analyzed using the Statistical Package for the Social
Sciences (SPSS), version 23. The qualitative variables were described
using frequencies and percentages. In addition, for the quantitative var-
iables, the mean and standard deviation were calculated. For the bivar-
iate analysis, the Pearson's chi-squared test was used, together with the
Student's t-test, and the study was concluded using backward selection
for binary logistic regression. The level of significance was set at p b .05
with a 95% confidence interval.
Findings
Sociodemographic and gynecological characteristics
Up to 45.15% (135) of study participants reported suffering from
menstrual migraine. No differences were found when comparing the
proportion of students with migraine of different ages (p = .398). The
mean age of the women with menstrual migraine was 20.43 ± 2.77
compared to 19.86 ± 2.02 among those who did not report this symp-
tom (p = .041). No differences were found regarding height, weight,
nor BMI, as this was analyzed as a quantitative variable. However,
when analyzing the BMI categorized according to theWHO, statistically
significant differences were found in relation to menstrual headaches
(p = .033) as women with normal weight were less affected by this
symptom (90 participants, 40.91%), compared to thosewith lowweight
(27 participants, 61.36%) or those who were overweight (18 partici-
pants, 51.43%). The regularity of the cycle, the duration of the same
and volume of the bleedingwere similar both inwomenwithmigraines
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mean age among women without migraines was 12.33 ± 1.38 com-
pared to 12.51 ± 1.52 among women with migraines (p = .300).
Concerning the use of hormonal contraceptives, a higher pro-
portion of women with menstrual migraine was identified among
women using contraceptives (29 participants, 58%) compared to
those not using oral contraceptives (106 participants, 42.6%)
(p = .045). All the women who reported menstrual migraine also
experienced one or more symptoms associated to menstruation,
with over half of women (120 participants, 52.6%) suffering from
both dysmenorrhea and menstrual migraine. However, among the
women who did not suffer dysmenorrhea, only 21.1%(15) (experi-
enced headaches) (p = .000). When analyzing the intensity of dys-
menorrhea using the VAS scale, higher scores were identified in
participants with menstrual headache (6.80 ± 2.05 vs 5.67 ±
2.30, p b .001).
Digestive symptoms, such as nausea, vomiting and diarrhea, were
reported in similar rates in women with and without migraine. In
women with migraine there was a greater proportion of women
experiencing sleep disorders (43 participants, 31.85% vs 33 partici-
pants, 20.12%, p = .20). Fatigue and tiredness during menstruation
affected 70.6%(211) of all women. Tiredness was the most prevalent
symptom among those with migraine during their period (109 par-
ticipants, 80.74% vs 102 participants, 62.20%). Regarding dizziness,
64.7% (44) of womenwho reported dizziness also experienced head-
aches during their menstruation (p b .001). Up to 92.59%(125) of
women whit menstrual headache, also had bloating. However,
bloating was only experienced by 82.93%(136) of those not mani-
fested pain (p = .013). Up to 85.93%(116) of women who experi-
enced menstrual migraine also experienced irritability during their
period, compared to 68.29%(112) who did not suffer from migraine
(p b .001). Up to 70.37%(95)of the women who had menstrual mi-
graine also felt depressed, however, among those who did not reportTable 1
Gynecological characteristics and menstrual migraine.
Gynecological characteristics Menstru
No
Regular cycle No 111(55.5
Yes 53(53.5%
Cycle duration ≤ 21 days 4(80%)
22–28 days 74(55.2%
≥ 29 86(53.8%
Duration of bleeding 3 to 5 days 113(57.7
6 to 11 days 50(49%)










Sleep disorder No 131(58.7
Yes 33(43.4%






Feeling depressed No 79(66.4%
Yes 85(47.2%




this symptom, only 51.83% (85)felt depressed during the days of
menstruation (p = 001). Of the women whit menstrual migraine,
70.37%(95) had to miss university classes or activities, compared to
52.44%(86) who experienced other menstrual symptoms
(p = .002). (Table 1).Lifestyle and menstrual migraine
In total, 84.3% of participants (252) lived in an urban environment.
Up to 35.12% (105) acknowledged practicing at least 3 h of exercise
per week and the mean number of hours of physical exercise was
slightly less amongwomenwhodid not suffer frommenstrualmigraine
(2.42 ± 2.47 vs 2.95 ± 2.86, p = .092).
Regarding consumption of drugs, 15.7% (47) of women smoked and
27.1% (81) drank alcohol every week. This proportion was similar
among those with menstrual migraine and those who did not.
Concerning water intake, this was similar in both groups (p = .631).
Likewise, the daily servings of dairy products were also similar: 2.40
± 1.57 in women with headaches compared to 2.21 ± 1.36 in those
who did not experience headaches (p = .253). The number of cups of
coffee per day consumed among women with, and without, headaches
was also similar (0.64± 0.78 compared to 0.68± 0.96) (p=7.03). The
mean number of daily servings of fruit was slightly higher among
women who did not experienced the problem (2.02 ± 1.09 vs1.84 ±
1.08, p = .170). Up to 59.2% (42) of women who drank cola beverages
suffered menstrual migraine compared to 40.8% (93) of those who did
not drink cola beverages, this finding was statistically significant (p =
.007) (Table 2).
Concerning the perceived quality of life rated from 0 to 100, al-
though the mean scores of women with menstrual migraine were
slightly lower, this was not statistically significant (78.38 ± 15.27 vs
79.72 ± 13.66).al migraine p-value
Yes Total





%) 83(42.3%) 196(65.8%) .155
52(51%) 102(34.2%)
%) 106(42.6%) 249(83.3%) .045⁎
29(58%) 50(16.7%)
) 15(21.1%) 71(23.7%) .000⁎
%) 120(52.6%) 228(76.3%)
%) 91(39.4%) 231(77.3%) .000⁎
) 44(64.7%) 68(22.7%)
%) 94(42.3%) 222(74.2%) .098
) 41(53.2%) 77(25.8%)
) 76(44.7%) 170(56.9%) .859
) 59(45.7%) 129(43.1%)
%) 92(41.3%) 223(74.6%) .020⁎
) 43(56.6%) 76(25.4%)
) 26(29.5%) 88(29.4%) .000⁎
%) 109(51.7%) 211(70.6%)
) 10(26.3%) 38(12.7%) .013⁎
%) 125(47.9%) 261(87.3%)
) 19(26.8%) 71(23.7%) .000⁎
%) 116(50.9%) 228(76.3%)
) 40(33.6%) 119(39.8%) .001⁎
) 95(52.8%) 180(60.2%)
) 40(33.9%) 118(39.5%) .002⁎
) 95(52.5%) 181(60.5%)
Table 2
Lifestyle and menstrual migraine.
Menstrual migraine p-Value
No Yes Total
Environment Rural 22(46.8%) 25(53.2%) 47(15.7%) .228
Urban 142(56.3%) 110(43.7%) 252(84.3%)
Smoking No 140(55.6%) 112(44.4%) 252(84.3%) .570
Yes 24(51.1%) 23(48.9%) 47(15.7%)
Alcohol No 114(52.3%) 104(47.7%) 218(72.9%) .145
Yes 50(61.7%) 31(38.3%) 81(27.1%)
Fast food No 128(55.2%) 104(44.8%) 232(77.6%) .835
Yes 36(53.7%) 31(46.3%) 67(22.4%)
Energy drinks No 154(55.2%) 125(44.8%) 279(93.3%) .652
Yes 10(50%) 10(50%) 20(6.7%)
Chocolate No 99(58.6%) 70(41.4%) 169(56.5%) .139
Yes 65(50%) 65(50%) 130(43.5%)
Cola beverages No 135(59.2%) 93(40.8%) 228(76.3%) .007⁎
Yes 29(40.8%) 42(59.2%) 71(23.7%)
Tea No 133(55.6%) 106(44.4%) 239(79.9%) .579
Yes 31(51.7%) 29(48.3%) 60(20.1%)
Coffee No 87(54.7%) 72(45.3%) 159(53.2%) .961
Yes 77(55%) 63(45%) 140(46.8%)
Sweets No 70(55.1%) 57(44.9%) 127(42.5%) .936
Yes 94(54.7%) 78(45.3%) 172(57.5)
Always uses olive oil No 37(53.6%) 32(46.4%) 69(23.1%) .815
Yes 127(55.2%) 103(44.8%) 230(76.9%)
Daily fruit No 57(50%) 57(50%) 114(38.1%) .186
Yes 107(57.8%) 78(42.2%) 185(61.9%)
Vegetarian No 160(54.6%) 133(45.4%) 293(98%) .557
Yes 4(66.7%) 2(33.3%) 6(2%)
Fish No 9(5.5%) 5(3.7%) 14(4.7%) .467
Yes 155(54.4%) 130(45.6%) 285(95.3%)
Water 0 40(59.7%) 27(40.3%) 67(22.4%) .631
1 103(53.9%) 88(46.1%) 191(63.9%)
2 21(51.2%) 20(48.8%) 41(13.7%)
⁎ b0.05.
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The results of the logistic regression analysis using the significant bi-
variate variables is displayed in Table 3. The odds ofmenstrualmigraine
in participants with dysmenorrhea was 3.19 higher (OR 9.19; 95% CI
1.62–6.28), while among those who used hormonal contraceptives
this was 2.60 times higher (OR 2.60; 95% CI 1.30–5.20). In students
who manifested irritability this was 2.34 times higher (OR 2.34; 95%
CI 1.25–4.40); in those who presented dizziness this was 2.05 times
higher (OR 2.05; 95% CI 1.12–3.75) and for those who drank cola bever-
ages on a daily basis, the probability was 1.85 times higher (OR 1.85;
95% CI 1.04–3.32). Based on this model, we removed the variables that
were not statistically significant predictors in the multivariate model
(Table 3).
Discussion
In this study, we identified that 45.15% of women surveyed experi-
enced menstrual migraine. This rate is higher than a previous study by
Carman et al. (2018) among adolescents in Turkey (25.9%), and 28.2%
among young people in Croatia (Cvetković et al., 2014) and also higherTable 3
Regression on menstrual migraine and possible risk factors.
Β EE gl p-value OR 95%CI
Oral contraceptives 0.957 0.353 1 .007⁎ 2.60 1.30 5.20
Dysmenorrhea 1.159 0.346 1 .001⁎ 3.19 1.62 6.28
Dizziness 0.716 0.309 1 .021⁎ 2.05 1.12 3.75
Irritability 0.852 0.321 1 .008⁎ 2.34 1.25 4.40
Cola beverages 0.617 0.297 1 .038⁎ 1.85 1.04 3.32
Constant −2.247 0.402 1 .000 0.106
⁎ b0.05.
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than a report by Vetvik et al. (2014) among adult Norwegian women,
estimating a rate of 7.6%. This difference may be explained by the fact
that our study population are female university students, many of
whom live together in university residences or share flats with other
girls considering that women who live with other women are more
likely to suffer from menstrual migraine (Ferreira, Guilherme, Faria,
Borges, & Uchiyama, 2017).
Previous studies have identified moderate and high levels of stress
among nursing students, mainly associated to the performance of clini-
cal placements (Labrague et al., 2017). In turn, other studies relate stress
as a factor that triggers migraines (Parashar, Bhalla, Rai, Pakhare, &
Babbar, 2014). However, it is unlikely that the high prevalence of mi-
graine in our sample is justified exclusively by the fact that they are
nursing students and by their stress levels, since in our study we
found no differences in the prevalence of migraine among first year stu-
dents who did not undertake clinical placements and those who were
enrolled in other courses and attended clinical placements. Another as-
pect which may contribute to the high prevalence of menstrual mi-
graine is that all the participants were from the same geographic
region, considering that a recent study identified geographic risk factors
for migraines, such as climate and sunlight (Tai, Yet, Lim, Pow, & Goh,
2019).
Our study also identified that the presence of dysmenorrhea was as-
sociated with a 3.19 times (1.62–6.28) greater odds of suffering from
headache. This finding is in line with previous studies (Bianchin et al.,
2019; Carman et al., 2018; Evans, Brooks, Esterman, Hull, & Rolan,
2018). The prevalence of dysmenorrhea in our population was high
(76.3%) therefore this factor can contribute to the high prevalence of
menstrual migraine detected.
Although significant differences were not found for perceived qual-
ity of life among women according to whether or not they suffered
from menstrual migraine, the quality of life scores of women whit mi-
graine were slightly lower, which is in line with previous research.
This appears to be related with the limitation of recreational activities,
a greater absenteeism and a perceived reduction in quality of life, as
shown in previous studies among young people with migraine (Buse,
Rupnow, & Lipton, 2009; Mannix et al., 2016). Possibly, the lack of sig-
nificance found in our study may be related to the fact that we only
used a scale of 0 to 100 on self-perceived quality of life, therefore, future
studies should include a complete validated questionnaire on quality of
life, such as the EUROQOL-5D (Hernandez et al., 2018). According to the
literature, menstrual migraines produce incapacity that impact on fam-
ily, academic and work responsibilities, at a great socioeconomic cost
(Bigal & Lipton, 2009; Pavlović et al., 2015; Stang, Crown, Bizier,
Chatterton, & White, 2004). In the United States alone, the economic
loss due to the direct and indirect costs attributed to migraines, includ-
ing absenteeism and decreased performance, is estimated at thousands
of dollars per year (Bigal & Lipton, 2009).
Regarding lifestyle, over half of thewomen studiedwhowere taking
oral contraceptives reported experiencing menstrual migraine,
representing a 2.60 (1.30–5.20) increased odds of suffering migraine.
These findings are in line with previous studies, such as the study by
Bianchin et al. (2019).
Nonetheless, a recent study showed that hormonal preparations of
less than 20 μg of ethinyl estradiol, can help preventmenstrualmigraine
(Calhoun & Batur, 2017). In our study, the exact dose of ethinyl estradiol
which the participantswere takingwas not recorded, therefore it would
be interesting to include this in future studies.
In terms of dietary factors Carman et al. (2018), had already identi-
fied the consumption of cola beverages as a risk factor formenstrualmi-
graine among young women in Turkey. In addition Lee, Choi, Choi, and
Chung (2016), demonstrated an improvement of acute migraine after
abstinence from coffee. In our study, the consumption of daily cola bev-
erageswas associatedwith a 1.85 times (1.03–3.32) increased probabil-
ity of suffering menstrual migraine. Nonetheless, it is striking that a
study by Derry, Derry, and Moore (2014)states that caffeine
E. Fernández-Martínez, M.D.(M.D.) Onieva-Zafra, A. Abreu-Sánchez et al. Journal of Pediatric Nursing 56 (2021) e1–e6consumption contributes towards relieving headache when used in as-
sociation with analgesics. Therefore, future research should explore the
consumption of caffeine. Likewise, although coffee drinking and
smoking have been related with menstrual migraine in previous stud-
ies, in our study, no relationship was found with migraine (Carman
et al., 2018). Regarding smoking, this data should be interpreted with
caution, as in our sample only 15.7% of university students smoked cig-
arettes, which may have influenced the lack of significant findings.
The main implication for clinical practice is that this study has iden-
tified several factors related with menstrual migraine. Drinking cola
beverages is the main potential modifiable risk factor related with life-
style. An important obstacle for approaching this problem is that most
young people normalize menstrual migraine and seldom do they con-
sult professionals, therefore the techniques of health education formod-
ifying lifestyle should perhaps be developed using community
interventions. In addition, other potential risk factors were identified,
such as dysmenorrhea, dizziness and irritability. Further study of these
risk factors is necessary. It is important to consider that menstrual mi-
graine has certain unique characteristics compared to other types ofmi-
graine, such as the perception of greater pain, a longer duration, greater
resistance to pharmacological therapy and associationwith other symp-
tomswarranting consideration (Pavlović et al., 2015). Themanagement
and research of this topic is complex and, therefore, a multidisciplinary
approach is advised, involving primary care, neurology and gynecology
(Witteveen, van den Berg, & Vermeulen, 2017).
Among the various strategies that can be employed by the pediat-
ric nurse, community intervention strategies based on health educa-
tion are highlighted. Of these, those aimed at the entire educational
community and implemented in the school context could be very ef-
ficient. Including families and girls and adolescents of various ages in
these activities could benefit a large number of women at a very
low cost. It would be interesting if nursing students themselves during
their pediatric clinical practices could participate in such activities as
professionals and with their own testimonies. Furthermore, in the dif-
ferent regions of Spain there are currently many inequalities with re-
gard to the presence and absence of pediatric nurses in schools, their
presence favors and contributes to implementing more activities in
this line. Policies should consider the benefits of implementing this
figure at an international level.Application to practice
This study identified high rates of menstrual migraine among the
study sample, which was more prevalent in women who consumed
cola or used hormonal contraceptives. These findings highlight the
possibility of adopting new strategies based on lifestyle modification
in community interventions during childhood and adolescence. A
fundamental role of pediatric nursing is to facilitate the empower-
ment of women towards the self-management of their health. It
also possesses a relevant role in providing society with clear and
concise information on normal aspects of menstruation. Moreover,
nurses should explore other symptoms such as dysmenorrhea, irrita-
bility and menstrual dizziness in young people with menstrual mi-
graine for a comprehensive approach. In this sense, the pediatric
nurse is placed in the strategic position of promoting mother-
daughter communication in aspects related to women's health and
of favoring the ability of continued research in this line, which, in
turn, may deepen knowledge in other potential risk factors and facil-
itate the design of new non pharmacological strategies as for exam-
ple yoga, that has demonstrate benefits in the treatment of
dysmenorrhea on an international basis(McGovern & Cheung,
2018). In addition, pediatric nurses are charged with the role of ed-
ucating, training and mentoring nursing students, a role which
should seed the idea in our students of the importance of pediatric
nursing as a reference point in child and adolescent health.5
Limitations
One of the principal limitations of the present study relates to its
cross-sectional design conducted at a single faculty of nursing at a Span-
ish university, with a limited sample size. Furthermore, the information
was gathered using retrospective self-report. Another limitation was
that no information was collected regarding any mental health prob-
lems experienced by participants, nor did we record other stressors
present in the context of undergraduate nursing training that could po-
tentially influence migraine. Nonetheless, this study provides explor-
atory information regarding a problem which has been poorly studied
among Spanish women. In order to continue with this line of research,
we recommend that a multi-center study should be performed in the
future supported by data collection using a symptoms diary, comparing
the prevalence of menstrual migraine among young university women
with different degrees. In addition, it would also be interesting to con-
duct similar research among secondary education students across dif-
ferent regions of Spain.
Conclusions
In conclusion, many young nursing students suffer from menstrual
migraine. We identified a greater proportion of women with menstrual
migraine among those with dysmenorrhea, irritability and dizziness
and who used oral contraceptives and drank cola beverages on a daily
basis. Most of the students normalized menstrual migraine and few
consulted professionals, therefore health education techniques for life-
style modification should be developed based on community interven-
tions during childhood and adolescence. In this context, pediatric
nursing professionals fulfill an essential role by providing education in
women's health.
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